Castelleone, Italy

Sara Frattini

USPTO Granted Patents = 34 

 

Average Co-Inventor Count = 5.8

ph-index = 8

Forward Citations = 124(Granted Patents)


Location History:

  • Catelleone, IT (2014 - 2015)
  • Castelleone, IT (2013 - 2023)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
34 patents (USPTO):

Title: The Innovative Journey of Sara Frattini

Introduction: Sara Frattini, an accomplished inventor based in Castelleone, Italy, has made significant contributions to the field of pharmacology through his innovative work. With a remarkable portfolio of 33 patents, he has focused primarily on developing treatments for various diseases, particularly those affecting pulmonary health.

Latest Patents: Among his most recent inventions are the CCR2 receptor antagonists and their uses. This innovation pertains to novel antagonists for CCR2 (CC chemokine receptor 2) and their potential application in creating medicaments aimed at treating conditions such as asthma and chronic obstructive pulmonary disease (COPD). These groundbreaking inventions signify a substantial leap forward in targeted therapies for pulmonary diseases.

Career Highlights: Sara Frattini has built a commendable career, contributing his expertise to well-regarded companies in the pharmaceutical industry. Notable among these are Boehringer Ingelheim International GmbH and Centrexion Therapeutics Corporation. His work within these organizations has allowed him to collaborate with leading professionals and engage in cutting-edge research.

Collaborations: Throughout his career, Sara has collaborated with distinguished coworkers such as Riccardo Giovannini and Christoph Hoenke. These partnerships have enriched his research initiatives and have facilitated the development of innovative solutions for healthcare challenges.

Conclusion: Sara Frattini stands out as a prominent figure in the innovation landscape, with a focus on creating meaningful advancements in the treatment of pulmonary diseases. His extensive patent portfolio and commitment to improving health outcomes reflect his dedication to the field of pharmacology. As he continues to contribute to scientific advancements, his work embodies the spirit of innovation that drives progress in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…